Skip to content
Clinical Trials – home
SlovakiaBack to Slovakia

Clinical trials in Nove Mesto – page 23

368 clinical trials in Nove Mesto, Slovakia across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

SlovakiaOur site in SlovakiaKlinickeSkusky.sk(opens in a new tab)
Nove Mesto at a glance
368
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

368 trials in Nove Mesto

Open in trial search

Study on the Safety and Effectiveness of Peginterferon Beta-1a for Children and Teens with Relapsing-Remitting Multiple Sclerosis

Registered drugNo placebo
Countries:SlovakiaSlovakia
  • Participants:0–17 years
  • Substances:Interferon BETA-1A
  • Sponsor:Biogen Idec Research Limited

Study Comparing Sacituzumab Govitecan to Physician's Choice Treatment for Patients with Advanced Triple-Negative Breast Cancer

Registered drugNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Gilead Sciences Inc.

Hidradenitis

Not recruiting

Study of lutikizumab compared to placebo in adults and adolescents (age 12 and older) with moderate to severe Hidradenitis Suppurativa

Investigational
Countries:SlovakiaSlovakia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Lutikizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Study on the Effects of AZD5004 and Semaglutide for Adults with Type 2 Diabetes

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:AZD5004
  • Sponsor:AstraZeneca AB

Study Comparing Volrustomig with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:AstraZeneca AB

Study of RO7247669 at Different Doses for People with Previously Untreated Advanced Melanoma that Cannot be Removed by Surgery or Has Spread

InvestigationalNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:RO7247669
  • Sponsor:F. Hoffmann-La Roche AG

Study on Lutetium (177Lu) Vipivotide Tetraxetan for Men with Progressive Metastatic Castration-Resistant Prostate Cancer

Registered drugNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone Acetate
  • Sponsor:Novartis Pharma AG

Pemphigoid

Not recruiting

Study on Efgartigimod Alfa and Prednisone for Adults with Bullous Pemphigoid

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx

Study on the Effectiveness and Safety of Remibrutinib Compared to Placebo and Omalizumab in Adults with Chronic Spontaneous Urticaria Uncontrolled by Antihistamines

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Omalizumab
  • Sponsor:Novartis Pharma AG

Asthma

Not recruiting

Study on Long-Term Safety of Depemokimab for Adults and Adolescents with Severe Eosinophilic Asthma

InvestigationalNo placebo
Countries:CzechiaCzechia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Depemokimab
  • Sponsor:Glaxosmithkline Research & Development Limited

Study Comparing Entrectinib and Crizotinib for Patients with Advanced Non-Small Cell Lung Cancer with ROS1 Gene Changes, With or Without Brain Metastases

Registered drugNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Crizotinib
  • Sponsor:F. Hoffmann-La Roche AG

Title: Comparison of oral tebipenem pivoxil versus intravenous imipenem-cilastatin in adults with complicated urinary tract infection or acute pyelonephritis

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Cilastatin
  • Sponsor:Spero Therapeutics Inc.

Other cities in Slovakia

The busiest research cities in the country

All 88 cities in Slovakia

Clinical research in Nove Mesto

What the registry says about research in the country

01 Cardiovascular Diseases

Clinical trial activity in Nove Mesto includes research in cardiovascular diseases, with a focus on atrial fibrillation and stable angina pectoris. These studies are designed to assess new treatment options and confirm whether emerging therapies can better prevent complications or relieve symptoms.

  • Prevention of cardioembolic events in atrial fibrillation
  • Evaluation of anti-anginal effects in stable angina pectoris
  • Testing treatment effectiveness for ongoing heart-related conditions

Overall, this area reflects active work aimed at improving both protection from serious cardiovascular events and day-to-day symptom control.

02 Digestive System and Liver Disorders

Another important research focus is digestive system diseases, especially studies involving hepatic impairment and moderate or severe hepatic impairment. These trials look at how liver problems may affect the safety and behavior of investigational therapies, helping define whether treatments can be used more effectively in people with liver disease.

  • Study of liver-related effects on treatment use
  • Research involving hepatic impairment and liver problems
  • Assessment of safety and tolerability in patients with compromised liver function

This area supports safer prescribing decisions and better understanding of how new therapies perform in patients with liver conditions.

03 Nutritional and Metabolic Diseases

Trials in nutritional and metabolic diseases are centered on hypertriglyceridemia and severe hypertriglyceridemia, reflecting a clear effort to improve management of abnormal lipid levels. The research is mainly aimed at testing whether new therapies can lower triglycerides and support better metabolic health.

  • Reduction of fasting serum triglyceride levels
  • Studies in hypertriglyceridemia and severe hypertriglyceridemia
  • Evaluation of treatment effectiveness for lipid-related disorders

These studies are relevant for patients at risk of complications linked to elevated triglycerides and broader metabolic imbalance.

04 Unspecified Therapeutic Area

Some studies in the city span broader or not fully specified categories, but they still contribute to a diverse clinical research environment. The overall pattern suggests work across multiple medical fields, with a strong emphasis on evaluating new therapies, confirming benefits, and improving how existing conditions are managed.

  • Broad clinical research across multiple disease areas
  • Testing the value of emerging treatment approaches
  • Supporting better disease management through clinical evaluation

With several recruiting sites active, the local trial landscape in Slovakia remains focused on practical questions that matter for patient care.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.